Dana-Farber Cancer Institute Business Development Manager Salaries in Boulder
The average Dana-Farber Cancer Institute Business Development Manager in Boulder earns an estimated $140,584 annually, which includes an estimated base salary of $112,571 with a $28,014 bonus. Dana-Farber Cancer Institute's Business Development Manager compensation is $8,443 more than the US average for a Business Development Manager. Business Development Manager salaries at Dana-Farber Cancer Institute in Boulder can range from $64,000 - $240,000.
In Boulder, The Business Development Department at Dana-Farber Cancer Institute earns $24,204 more on average than the Operations Department.
Last updated a year ago.
- $112,571
- avg. base
- $28,014
- avg. bonus
Business Development Manager Salaries at Dana-Farber Cancer Institute
In Boulder, Business Development Managers earn $3,320 more than Business Development Managers.
Compensation at Dana-Farber Cancer Institute by Department
In Boulder, The Business Development Department averages $24,204 more than the Operations Department, and $3,902 less than the Finance Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Dana-Farber Cancer Institute reported making $126,047, while the average male Business Development Manager at similar sized companies reported making $134,824.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Native American Business Development Manager at companies similar size to Dana-Farber Cancer Institute reported making $195,000, while the average African American/Black Business Development Manager at similar sized companies reported making $88,600.
How Business Development Managers at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Business Development Managers at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Business Development Managers at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
